US2016052974A1PendingUtilityA1

Novel genes and proteins of brachyspira hyodysenteriae and uses thereof

37
Assignee: BELLGARD MATTHEWPriority: Aug 3, 2007Filed: Mar 30, 2015Published: Feb 25, 2016
Est. expiryAug 3, 2027(~1.1 yrs left)· nominal 20-yr term from priority
C07K 14/20G01N 33/56911A61P 37/04A61K 39/0225A61P 31/04A61K 2039/552G01N 2333/20
37
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Novel polynucleotide and amino acids of Brachyspira hyodysenteriae are described. These sequences are useful for diagnosis of B. hyodysenteriae disease in animals and as a therapeutic treatment or prophylactic treatment of B. hyodysenteriae disease in animals. These sequences may also be useful for diagnostic and therapeutic and/or prophylactic treatment of diseases in animals caused by other Brachyspira species, including B. intermedia, B. suantatina, B. alvinipulli, B. aalborgi, B. innocens, B. murdochii , and B. pilosicoli.

Claims

exact text as granted — not AI-modified
1 . An isolated polypeptide comprising the full length of an amino acid sequence selected from the group consisting of SEQ ID NO: 22, 32, and 64 with a heterologous polypeptide that permits the detection, isolation, solubilization, or stabilization of the isolated polypeptide. 
     
     
         2 - 5 . (canceled) 
     
     
         6 . An immunogenic composition comprising the polypeptide of  claim 1 . 
     
     
         7 - 30 . (canceled) 
     
     
         31 . A method of generating an immune response to  Brachyspira  infection in an animal comprising administering to said animal the polypeptide of  claim 1 . 
     
     
         32 - 44 . (canceled) 
     
     
         45 . An isolated polypeptide comprising a sequence that is at least 70% homologous to a polypeptide with an amino acid sequence selected from the group consisting of SEQ ID NO: 22, 32, and 64 and a heterologous polypeptide that permits the detection, isolation, solubilization, or stabilization of the isolated polypeptide. 
     
     
         46 . An isolated polypeptide comprising a sequence that is at least 80% homologous to a polypeptide with an amino acid sequence selected from the group consisting of SEQ ID NO: 22, 32, and 64 and a heterologous polypeptide that permits the detection, isolation, solubilization, or stabilization of the isolated polypeptide. 
     
     
         47 . An isolated polypeptide comprising a sequence that is at least 90% homologous to a polypeptide with an amino acid sequence selected from the group consisting of SEQ ID NO: 22, 32, and 64 and a heterologous polypeptide that permits the detection, isolation, solubilization, or stabilization of the isolated polypeptide. 
     
     
         48 . An immunogenic composition comprising the polypeptide of  claim 45 . 
     
     
         49 . A method of generating an immune response to  Brachyspira  infection in an animal comprising administering to said animal the polypeptide of  claim 45 . 
     
     
         50 . An immunogenic composition comprising the polypeptide of  claim 46 . 
     
     
         51 . A method of generating an immune response to  Brachyspira  infection in an animal comprising administering to said animal the polypeptide of  claim 46 . 
     
     
         52 . An immunogenic composition comprising the polypeptide of  claim 47 . 
     
     
         53 . A method of generating an immune response to  Brachyspira  infection in an animal comprising administering to said animal the polypeptide of  claim 47 .

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.